Jun Luo
Impact in
- Pulmonary and Respiratory Medicine top 0.1%
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
- Cancer Research top 0.5%
- Cancer Genomics and Diagnostics
- MicroRNA in disease regulation
Papers in
-
- Prostate Cancer Treatment and Research 118
- Prostate Cancer Diagnosis and Treatment 16
-
- Cancer Genomics and Diagnostics 7
- Co-authors
- William B. Isaacs (27 shared papers)Emmanuel S. Antonarakis (44 shared papers)Changxue Lu (25 shared papers)Rong Hu (5 shared papers)Angelo Michael De Marzo (23 shared papers)Charles M. Ewing (9 shared papers)Thomas A. Dunn (9 shared papers)Mario A. Eisenberger (14 shared papers)
- Journals
- The Prostate (20 papers)Cancer Research (11 papers)Prostate Cancer and Prostatic Diseases (10 papers)European Urology (9 papers)The Journal of Urology (5 papers)
- Partner nations
- United StatesChinaUnited Kingdom
In The Last Decade
Jun Luo
150 papers receiving 15.2k citations
Jun Luo's Hit Papers
Peers
Comparison fields: 5 of 131
- Pulmonary and Respiratory Medicine 9.8k
- Cancer Research 2.2k
- Oncology 997
- Molecular Biology 2.5k
- Urology 123
Countries citing papers authored by Jun Luo
This map shows the geographic impact of Jun Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Luo more than expected).
Fields of papers citing papers by Jun Luo
This network shows the impact of papers produced by Jun Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Luo. The network helps show where Jun Luo may publish in the future.
Co-authors
The 25 scholars most cited alongside Jun Luo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 159 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer Hit paper breakdown → | 2014 | 2246 |
| 2 | Ligand-Independent Androgen Receptor Variants Derived from Splicing of Cryptic Exons Signify Hormone-Refractory Prostate Cancer Hit paper breakdown → | 2008 | 907 |
| 3 | The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models Hit paper breakdown → | 2010 | 711 |
| 4 | Androgen Receptor Splice Variant 7 and Efficacy of Taxane Chemotherapy in Patients With Metastatic Castration-Resistant Prostate Cancer Hit paper breakdown → | 2015 | 528 |
| 5 | 2009 | 516 | |
| 6 | Distinct Transcriptional Programs Mediated by the Ligand-Dependent Full-Length Androgen Receptor and Its Splice Variants in Castration-Resistant Prostate Cancer Hit paper breakdown → | 2012 | 504 |
| 7 | Human prostate cancer and benign prostatic hyperplasia: molecular dissection by gene expression profiling. | 2001 | 406 |
| 8 | Clinical Significance of Androgen Receptor Splice Variant-7 mRNA Detection in Circulating Tumor Cells of Men With Metastatic Castration-Resistant Prostate Cancer Treated With First- and Second-Line Abiraterone and Enzalutamide Hit paper breakdown → | 2017 | 395 |
| 9 | 2009 | 374 | |
| 10 | 2004 | 367 | |
| 11 | 2008 | 357 | |
| 12 | Androgen receptor splice variant-7 expression emerges with castration resistance in prostate cancer Hit paper breakdown → | 2018 | 321 |
| 13 | Prospective Multicenter Validation of Androgen Receptor Splice Variant 7 and Hormone Therapy Resistance in High-Risk Castration-Resistant Prostate Cancer: The PROPHECY Study Hit paper breakdown → | 2019 | 309 |
| 14 | Alpha-methylacyl-CoA racemase: a new molecular marker for prostate cancer. | 2002 | 238 |
| 15 | 2013 | 225 | |
| 16 | 2015 | 214 | |
| 17 | 2013 | 182 | |
| 18 | 2011 | 180 | |
| 19 | 2014 | 160 | |
| 20 | 2018 | 159 |
About Jun Luo
Jun Luo is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research, Oncology, Genetics and Molecular Biology, having authored 159 papers that have together received 15.5k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (118 papers), Prostate Cancer Diagnosis and Treatment (16 papers), BRCA gene mutations in cancer (7 papers), Cancer Genomics and Diagnostics (7 papers), Gene expression and cancer classification (4 papers), PARP inhibition in cancer therapy (3 papers), Acute Myeloid Leukemia Research (3 papers) and Fluid Dynamics and Mixing (3 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (9.8k citations), Cancer Research (2.2k citations), Oncology (997 citations), Molecular Biology (2.5k citations) and Urology (123 citations). Jun Luo has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include William B. Isaacs, Emmanuel S. Antonarakis, Changxue Lu, Rong Hu, Angelo Michael De Marzo, Charles M. Ewing, Thomas A. Dunn, Mario A. Eisenberger, Michael Anthony Carducci and Samuel Ray Denmeade. Their work appears in journals such as The Prostate, Cancer Research, Prostate Cancer and Prostatic Diseases, European Urology and The Journal of Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.